James Lewis

In this session we will learn about the exciting advances in mechanisms by which microbial metabolites as well can drive metabolic disorders and the pipeline of potential microbial therapeutics to treat metabolic disorders…

In this session we will learn about the exciting advances in mechanisms by which microbial metabolites as well can drive metabolic disorders and the pipeline of potential microbial therapeutics to treat metabolic disorders…

SOCIETY: AGA

BACKGROUND: Perianal fistulizing complications (PFC) of Crohn’s disease (CD) are highly morbid and difficult to treat. Despite the advent of biologic medications, antibiotics remain a mainstay of PFC treatment…

BACKGROUND: The Nordic-European Initiative on Colorectal Cancer (NordICC) Study highlighted the impact of adherence on the effectiveness of colonoscopy at reducing CRC incidence and mortality…

Obesity is prevalent within the inflammatory bowel disease (IBD) population. Several studies suggest that 15%-40% of IBD patients are obese. Obesity has further been associated with higher disease activity and reduced time to flare…

BACKGROUND: There is a growing population of patients with end-stage renal disease (ESRD) on hemodialysis (HD) in the United States who frequently require screening or diagnostic and therapeutic endoscopic procedures…